Basic Information
IMT is the first company to design targeted treatments for the root causes of autoimmune diseases, specifically targeting HLA variants known to confer a high risk of disease.
ImmunoMolecular Therapeutics
Massachusetts,United States of America
less than 15 people
January 01, 2015
info@imtherapeutics.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios